semaglutide and bone density Recent 2026 studies indicate that rapid weight loss from GLP-1 drugs like Ozempic can lead to significant loss a higher risk of musculoskeletal injuries, including a nearly 30% increased Effects of Glucagon-Like Peptide-1 receptor
Description
Novo Nordisk says the US FDA has approved a once daily pill

Ivim Health review: we scored it 4.9/5 a top-tier pick

Discover effective strategies for Weight Loss, including insights on GLP-1 and managing type 2 diabetes
THURSDAY, June 25, 2026 (HealthDay News) As the use of GLP-1 medications for weight loss surges, so do calls to U.S